Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory DLBCL Patients
Clinical trial NCT02374424 · TERMINATED
Trial details
- NCT number
- NCT02374424
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-05
- Primary completion
- 2018-02-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.